Novo Nordisk Confirms Cyberattack Exposing Pseudonymized Clinical Trial Data and Alleged AI Assets

On 12 June 2026, Novo Nordisk A/S announced that attackers had accessed and exfiltrated a limited set of its internal da...

Read story →